Tempus AI announced plans to raise $350 million through a convertible senior notes offering in a private placement, with net proceeds intended primarily to refinance debt. The company said it will use proceeds to repay $307.7 million of outstanding loans, accrued interest, and transaction-related fees, including capped call transactions to reduce dilution and hedging costs. Tempus also indicated the financing could support acquisitions, strategic investments, and general corporate purposes. Notes would be due in 2032, and initial buyers may purchase an additional $52.5 million of notes under an option. Tempus previously completed similar convertible offerings in prior years to pay down debt and manage interest expense. From an industry perspective, the raise signals continued investment capacity for Tempus’ multimodal oncology diagnostics platform while managing balance-sheet risk through refinancing rather than pure incremental burn.